• Prostate zones and cancer: lost in transition?

      Ali, Amin; orcid: 0000-0003-4876-0626; Du Feu, Alexander; orcid: 0000-0002-3084-4525; Oliveira, Pedro; Choudhury, Ananya; Bristow, Robert G; orcid: 0000-0002-8553-9544; Baena, Esther; orcid: 0000-0003-4157-3684; email: esther.baena@cruk.manchester.ac.uk (2021-10-19)
      Localized prostate cancer shows great clinical, genetic and environmental heterogeneity; however, prostate cancer treatment is currently guided solely by clinical staging, serum PSA levels and histology. Increasingly, the roles of differential genomics, multifocality and spatial distribution in tumorigenesis are being considered to further personalize treatment. The human prostate is divided into three zones based on its histological features: the peripheral zone (PZ), the transition zone (TZ) and the central zone (CZ). Each zone has variable prostate cancer incidence, prognosis and outcomes, with TZ prostate tumours having better clinical outcomes than PZ and CZ tumours. Molecular and cell biological studies can improve understanding of the unique molecular, genomic and zonal cell type features that underlie the differences in tumour progression and aggression between the zones. The unique biology of each zonal tumour type could help to guide individualized treatment and patient risk stratification. [Abstract copyright: © 2021. Springer Nature Limited.]
    • Spatiofunctional Dynamics of NKX3.1 to Safeguard the Prostate from Cancer.

      Finch, Andrew J; orcid: 0000-0002-8065-4623; Baena, Esther; orcid: 0000-0003-4157-3684; email: esther.baena@cruk.manchester.ac.uk (2021-09)
      A novel role of NKX3.1 in the mitochondria regulating the transcription of the electron transport chain components is reported. Mechanistically, HSPA9 chaperones NKX3.1 into the mitochondria in response to oxidative stress to regulate reactive oxygen species and suppress tumor initiation. . [Abstract copyright: ©2021 American Association for Cancer Research.]